The founder of a successful public biotechnology company once told me ... The founder concluded: “There are many more good ideas than good managers in the world. That's the pity!” ...

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

Boston is not just a hub for history buffs and sports enthusiasts; it’s also a powerhouse of innovation that propels the ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

Axon Enterprise (NASDAQ:AXON – Free Report) had its price objective upped by Northland Securities from $365.00 to $550.00 in ...

Venturi Wealth Management LLC grew its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 28.1% in the third ...

South-East Asia will now have its first dedicated Process Technology show with the launch of Process Innovation Asia Pacific ...

Let’s look at where Sana Biotechnology, Inc. (SANA) stands against other penny stocks with the biggest upside potential. The Federal Reserve slashed interest rates by a half point in September ...

The JNU academic council approved the proposal to introduce a Postgraduate Diploma in Biotechnology and an MSc (Research) in ...

Puma Biotechnology Inc (PBYI) reports a significant revenue increase and outlines future business development opportunities amidst ongoing challenges.